Cite
Fountzilas E, Kotoula V, Koliou GA, et al. Pathogenic mutations and overall survival in 3,084 patients with cancer: the Hellenic Cooperative Oncology Group Precision Medicine Initiative. Oncotarget. 2020;11(1):1-14doi: 10.18632/oncotarget.27338.
Fountzilas, E., Kotoula, V., Koliou, G. A., Giannoulatou, E., Gogas, H., Papadimitriou, C., Tikas, I., Zhang, J., Papadopoulou, K., Zagouri, F., Christodoulou, C., Koutras, A., Makatsoris, T., Chrisafi, S., Linardou, H., Varthalitis, I., Papatsibas, G., Razis, E., Papakostas, P., Samantas, E., Aravantinos, G., Bafaloukos, D., Kosmidis, P., Koumarianou, A., Psyrri, A., Pentheroudakis, G., Pectasides, D., Futreal, A., Fountzilas, G., & Tsimberidou, A. M. (2020). Pathogenic mutations and overall survival in 3,084 patients with cancer: the Hellenic Cooperative Oncology Group Precision Medicine Initiative. Oncotarget, 11(1), 1-14. https://doi.org/10.18632/oncotarget.27338
Fountzilas, Elena, et al. "Pathogenic mutations and overall survival in 3,084 patients with cancer: the Hellenic Cooperative Oncology Group Precision Medicine Initiative." Oncotarget vol. 11,1 (2020): 1-14. doi: https://doi.org/10.18632/oncotarget.27338
Fountzilas E, Kotoula V, Koliou GA, Giannoulatou E, Gogas H, Papadimitriou C, Tikas I, Zhang J, Papadopoulou K, Zagouri F, Christodoulou C, Koutras A, Makatsoris T, Chrisafi S, Linardou H, Varthalitis I, Papatsibas G, Razis E, Papakostas P, Samantas E, Aravantinos G, Bafaloukos D, Kosmidis P, Koumarianou A, Psyrri A, Pentheroudakis G, Pectasides D, Futreal A, Fountzilas G, Tsimberidou AM. Pathogenic mutations and overall survival in 3,084 patients with cancer: the Hellenic Cooperative Oncology Group Precision Medicine Initiative. Oncotarget. 2020 Jan 07;11(1):1-14. doi: 10.18632/oncotarget.27338. eCollection 2020 Jan 07. PMID: 32002119; PMCID: PMC6967777.
Copy
Download .nbib